|
YOU ARE HERE: Funds » »
News:
MorphoSys and Xencor Complete Enrollment in MOR208 (Xmab5574) Phase 1 Trial in CLL PR Newswire - 0 mins ago Phase 3 MISSION trial of Nexavar (sorafenib) in Patients with Non-Small Cell Lung Cancer Did Not Meet Primary Endpoint of Improving Overall Survival PR Newswire - 5 mins ago Genpact Signs Business Process Management Engagement with Dr. Reddy's Laboratories PR Newswire - 5 mins ago Organizers: Don't mess with the Olympic brand AP - 17 mins ago Cartoon studio faces state clout, global stars AP - 18 mins ago Malaysia, Australia ink free trade pact AP - 30 mins ago Allot Supercharges Proactive Analytics Suite PR Newswire - 35 mins ago Rare protests in Myanmar against power cuts AP - 59 mins ago Comstock Mining Notice From BLM PR Newswire - 1 hr 4 mins ago
![]()
![]()
Symbols:
Top Stocks Futures Markets My Stocks Save Cancel
FlipCharts
Daily information as of Tuesday, May 22nd, 2012, based on end-of-day data.
Main View
Technical Performance Custom View
|



